genomics

By  Dave Muoio 01:56 pm February 16, 2021
SNP chips, a type of DNA microarray frequently employed by consumer genomics companies, are "extremely unreliable" when identifying clinically-relevant variants that are rare among the general population, according to a retrospective study recently published in The BMJ. The investigation, conducted by researchers from the University of Exeter, reviewed sequencing data from nearly 50,000...
genomics, AI

Credit: Eagle Genomics

By  Sophie Porter 02:47 am October 28, 2020
Eagle Genomics, a medtech company pioneering the application of network science to microbiome biology, has closed a round of $9 million (€7.6m) scale-up funding. The funding was led by the Environmental Technologies Fund (ETF) and a consortium of investors headed by Granpool Innovative Investments and including Albert-László Barabási, bpd partners and Anatom Holding. The funding will allow the...
By  Dr. Liz Kwo 12:00 pm September 11, 2020
About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem, and previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health. COVID-19 has reshaped the way humans interact with technology in...
By  Dave Muoio 04:13 pm July 10, 2019
Clover Health, an Alphabet-backed insurtech startup serving the Medicare Advantage market, announced this morning the launch of a new subsidiary unit that will be focused on using data from its members to drive drug development. Much like its parent company uses machine learning and artificial intelligence to generate predictive health insights for its member population, Clover Therapeutics will...
By  Joshua Barrett and Dan Gebremedhin 11:41 am June 21, 2019
About the Authors: Joshua Barrett is a member of the 2019 Flare Capital Partners Scholar program and a third-year medical student at Georgetown University School of Medicine, who completed his MBA at the Columbia Business School. He plans to pursue a career in healthcare technology or life sciences investing. Dr. Dan Gebremedhin (@dangebremedhin) is a partner at Flare Capital Partners, a...
By  Dave Muoio 09:47 am June 13, 2019
Genome Medical — a company that offers patient-facing virtual visits and provider-facing consultations with genetic experts — has raised $23 million in Series B funding. The round brings Genome Medical to $46 million in total funding. The round was led by Echo Health Ventures, with participation from LRVHealth, Casdin Capital, Perceptive Advisors, Manatt Venture Fund and Dreamers Fund, as well as...
By  Dave Muoio 02:00 pm June 11, 2019
Mount Sinai’s Icahn School of Medicine has revealed plans for a new center for research, development and implementation of artificial intelligence for healthcare. Called the Hamilton and Amabel James Center for Artificial Intelligence and Human Health, the Manhattan site is scheduled to open its doors sometime in the later part of 2021. The school is looking to have roughly 40 principal...
By  Laura Lovett 11:52 am June 11, 2019
Less than a year after the blockchain-enabled genome sequencing startup's launch, Nebula Genomics is announcing its first pharma partnership with Merck KGaA’s EMD Serono. This early partnership will come in the form of a pilot program.  As part of the deal, EMD Serono will be able to use Nebula’s network of anonymized genomic data. This new pilot is specifically zeroing in on lung cancer patients...
Doctor talking to patient
By  Piers Ford 06:57 am February 13, 2019
Mendelian, a UK healthtech startup, has received a £500,000 grant from Innovate UK to build platforms that will help GPs to identify NHS patients with potentially rare or hard-to-diagnose conditions and diseases more quickly. The two-year £940,000 project is based on Mendelian’s specialised screening system, which provides augmented and automated data analysis to assist with the accurate...
By  Laura Lovett 03:30 pm December 11, 2018
A new company called LunaDNA has created an avenue for people to donate their health data in exchange for shares in the company. The novel platform seeks to serve the needs of nonprofit and for-profit researchers as well as everyday people willing to share their health data.  “What we aim to do is create a human health database, inclusive of DNA data, clinical, medical, contextual information....